Unibest
← Back to patent-cliff list

Nitisinone

Tier C — Watch / trade

Nitisinone

Swedish Orphan Biovitrum Ag
Originator
2002
First approval
-
Expiry (public)
$0.1B ▲
Peak sales
Small molecule
Type

Targets:4HPPD

Brand:HARLIKU, Orfadin, Nityr

Indications (approved):黑尿症, 酪氨酸血症

Regional status

US
Approved
2002-01-18
EU
Approved
2005-02-20
China
Approved
2021-06-16
Japan
Approved
2014-12-26

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 1 · Total yield /
NITI-001504-02-9NITI-00281108-81-8API · Nitisinone
CodeCAS No.Intermediate
NITI-001504-02-9cyclohexane-1,3-dione
NITI-00281108-81-82-nitro-4-(trifluoromethyl)benzoyl chloride

Frequently asked questions

What are the approved indications of Nitisinone?

Approved indications include: 黑尿症, 酪氨酸血症.

When does the Nitisinone patent expire?

No public expiry year is available for Nitisinone yet; this page updates once verified.

How many synthesis routes are recorded for Nitisinone?

1 synthesis routes are recorded; the shortest is 1 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Nitisinone intermediates?

All intermediates in Nitisinone routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Nitisinone intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29